HUE066769T2 - Neurodegeneratív szembetegség kezelése pridopidinnal - Google Patents
Neurodegeneratív szembetegség kezelése pridopidinnalInfo
- Publication number
- HUE066769T2 HUE066769T2 HUE17757261A HUE17757261A HUE066769T2 HU E066769 T2 HUE066769 T2 HU E066769T2 HU E17757261 A HUE17757261 A HU E17757261A HU E17757261 A HUE17757261 A HU E17757261A HU E066769 T2 HUE066769 T2 HU E066769T2
- Authority
- HU
- Hungary
- Prior art keywords
- pridopidine
- treatment
- eye disease
- neurodegenerative eye
- neurodegenerative
- Prior art date
Links
- 208000030533 eye disease Diseases 0.000 title 1
- 230000000626 neurodegenerative effect Effects 0.000 title 1
- YGKUEOZJFIXDGI-UHFFFAOYSA-N pridopidine Chemical compound C1CN(CCC)CCC1C1=CC=CC(S(C)(=O)=O)=C1 YGKUEOZJFIXDGI-UHFFFAOYSA-N 0.000 title 1
- 229950003764 pridopidine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662299290P | 2016-02-24 | 2016-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE066769T2 true HUE066769T2 (hu) | 2024-09-28 |
Family
ID=59686581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17757261A HUE066769T2 (hu) | 2016-02-24 | 2017-02-24 | Neurodegeneratív szembetegség kezelése pridopidinnal |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11738012B2 (https=) |
| EP (1) | EP3419622B1 (https=) |
| JP (1) | JP7034488B2 (https=) |
| AU (1) | AU2017223838B2 (https=) |
| CA (1) | CA3015512C (https=) |
| DK (1) | DK3419622T3 (https=) |
| ES (1) | ES2979123T3 (https=) |
| HU (1) | HUE066769T2 (https=) |
| PL (1) | PL3419622T3 (https=) |
| WO (1) | WO2017147366A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| US11471449B2 (en) | 2015-02-25 | 2022-10-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| US20220062255A1 (en) * | 2016-02-24 | 2022-03-03 | Prilenia Neurotherapeutics Ltd. | Treatment of neurodegenerative eye disease using pridopidine |
| CA3035099C (en) | 2016-08-24 | 2023-01-17 | Prilenia Therapeutics Development Ltd. | Use of pridopidine for treating dystonias |
| EP4516356A3 (en) | 2016-08-24 | 2025-05-14 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating functional decline |
| US12102627B2 (en) | 2016-09-16 | 2024-10-01 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating rett syndrome |
| US12036213B2 (en) | 2017-09-08 | 2024-07-16 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating drug induced dyskinesias |
| JP2020533296A (ja) | 2017-09-08 | 2020-11-19 | プリレニア ニューロセラピューティクス リミテッド | 薬物誘発性ジスキネジアを治療するためのプリドピジン |
| CN113395964A (zh) | 2019-02-04 | 2021-09-14 | 普瑞尼亚神经治疗有限公司 | 用于帕金森氏病和与帕金森症相关的其它疾病的低剂量普利多匹定 |
| AU2020243692B2 (en) * | 2019-03-15 | 2023-03-02 | Prilenia Neurotherapeutics Ltd. | Treatment of mitochondrial associated diseases and disorders, including symptoms thereof using pridopidine |
| JP7829678B2 (ja) * | 2021-10-11 | 2026-03-13 | プリレニア ニューロセラピューティクス リミテッド | 神経変性眼疾患を治療するためのプリドピジン及びその類似体 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| IL134241A (en) * | 2000-01-27 | 2006-06-11 | Finetech Pharmaceutical Ltd | Process for the preparation of latanoprost |
| WO2004103263A2 (en) * | 2003-05-22 | 2004-12-02 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for treatment of neurodegenerative diseases |
| SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| CA2584831C (en) | 2004-10-13 | 2013-09-17 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| CN101711236B (zh) | 2007-04-12 | 2012-10-31 | Nsab神经研究瑞典公司分公司 | 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物 |
| EP2170343A1 (en) | 2007-05-31 | 2010-04-07 | Joseph Weinstock | Treatment of age-related macular degeneration |
| AU2008296908B2 (en) * | 2007-09-05 | 2014-01-09 | Teva Pharmaceutical Industries, Ltd. | Method of treating glaucoma using rasagiline |
| US20110206782A1 (en) * | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of dopamine receptor |
| WO2011107583A1 (en) * | 2010-03-04 | 2011-09-09 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| BR112014005389A8 (pt) | 2011-09-07 | 2018-04-03 | Ivax Int Gmbh | Sal cloridrato de 4- (3-metanossulfonil-fenil) -1- propil-piperidina em uma forma cristalina, composição farmacêutica compreendendo o mesmo e usos do dito sal |
| TWI579272B (zh) | 2011-12-08 | 2017-04-21 | 梯瓦製藥國際有限責任公司 | 普多比啶（ｐｒｉｄｏｐｉｄｉｎｅ）之氫溴酸鹽 |
| AU2013243461A1 (en) | 2012-04-04 | 2014-11-06 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
| US20150216850A1 (en) * | 2012-09-27 | 2015-08-06 | Michael Hayden | Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease |
| HK1221646A1 (zh) | 2013-06-21 | 2017-06-09 | Teva Pharmaceuticals International Gmbh | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| MX377576B (es) | 2014-01-22 | 2025-03-04 | Prilenia Neurotherapeutics Ltd | Formulaciones de pridopidina de liberación modificada. |
| TW201613859A (en) | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
| MX2017008136A (es) | 2014-12-22 | 2018-03-06 | Teva Pharmaceuticals Int Gmbh | Sal de l-tartrato de pridopidina. |
| WO2016138135A1 (en) | 2015-02-25 | 2016-09-01 | Teva Pharmaceuticals International Gmbh | Sigma-1 receptor modulators for treating huntington's disease |
| JP6887952B2 (ja) | 2015-02-25 | 2021-06-16 | プリレニア ニューロセラピューティクス リミテッド | 認知機能を改善するため、およびアルツハイマー病を治療するためのプリドピジンの使用 |
| EP3324967A4 (en) | 2015-07-22 | 2019-03-20 | Prilenia Therapeutics Development Ltd. | PRIDOPIDINE-BASED FORMULATIONS AND USE OF THE SAME |
| AR105434A1 (es) | 2015-07-22 | 2017-10-04 | Teva Pharmaceuticals Int Gmbh | Proceso para preparar pridopidina |
| KR20200031446A (ko) | 2018-09-14 | 2020-03-24 | 삼성전자주식회사 | 무선 통신 시스템에서 pdcch 모니터링 방법 및 장치 |
-
2017
- 2017-02-24 JP JP2018544853A patent/JP7034488B2/ja active Active
- 2017-02-24 EP EP17757261.7A patent/EP3419622B1/en active Active
- 2017-02-24 WO PCT/US2017/019266 patent/WO2017147366A1/en not_active Ceased
- 2017-02-24 ES ES17757261T patent/ES2979123T3/es active Active
- 2017-02-24 AU AU2017223838A patent/AU2017223838B2/en active Active
- 2017-02-24 PL PL17757261.7T patent/PL3419622T3/pl unknown
- 2017-02-24 CA CA3015512A patent/CA3015512C/en active Active
- 2017-02-24 DK DK17757261.7T patent/DK3419622T3/da active
- 2017-02-24 HU HUE17757261A patent/HUE066769T2/hu unknown
- 2017-02-24 US US16/078,929 patent/US11738012B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017147366A1 (en) | 2017-08-31 |
| US20190046516A1 (en) | 2019-02-14 |
| CA3015512A1 (en) | 2017-08-31 |
| EP3419622B1 (en) | 2024-03-06 |
| DK3419622T3 (da) | 2024-06-03 |
| PL3419622T3 (pl) | 2024-07-08 |
| ES2979123T3 (es) | 2024-09-24 |
| AU2017223838B2 (en) | 2022-09-29 |
| JP7034488B2 (ja) | 2022-03-14 |
| EP3419622A4 (en) | 2019-07-10 |
| US11738012B2 (en) | 2023-08-29 |
| EP3419622A1 (en) | 2019-01-02 |
| JP2019507758A (ja) | 2019-03-22 |
| AU2017223838A1 (en) | 2018-09-06 |
| CA3015512C (en) | 2024-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190117T1 (hr) | iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA | |
| HUE066769T2 (hu) | Neurodegeneratív szembetegség kezelése pridopidinnal | |
| ZA201807084B (en) | Methods of treatment of cholestatic diseases | |
| PT3212233T (pt) | Terapia combinada para o tratamento de doenças | |
| IL255423A0 (en) | Methods for treating neurodegenerative disease | |
| IL269106A (en) | Methods for the treatment of neurodegenerative diseases | |
| IL247085B (en) | Methods for treating Alzheimer's disease | |
| ZA201903003B (en) | Treatment of neurological diseases | |
| IL267229A (en) | Methods of treating ocular disorders | |
| IL246999A0 (en) | Methods for treating Alzheimer's disease | |
| GB201608046D0 (en) | Treatment of complement-mediated disorders | |
| GB201516905D0 (en) | Treatment of Neurodegenerative diseases | |
| EP3157631A4 (en) | Neurodegenerative disease treatment | |
| GB201412578D0 (en) | Treatment of neurological diseases | |
| EP3145532A4 (en) | Individualized treatment of eye disease | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| GB201714307D0 (en) | Treatment of neurodegenerative diseases | |
| EP3474876A4 (en) | TREATMENT OF MORBUS CANAVAN | |
| IL263837A (en) | Treatment of ocular disease | |
| GB201411616D0 (en) | Diagnosis and treatment of neurodegenerative disorders | |
| GB201714311D0 (en) | Treatment of neurodegenerative diseases | |
| GB201714303D0 (en) | Treatment of neurodegenerative diseases | |
| GB201604359D0 (en) | Treatment of tissue disorders | |
| SI3903774T1 (sl) | N,N-bis-2-merkaptoetil izoftalamid za zdravljenje nevrodegenerativnih bolezni | |
| GB201610938D0 (en) | Treatment of ocular disease |